Page 105 - 2023-05-中国全科医学

·618· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn February 2023, Vol.26 No.5

predicts the outcome of COVID-19 independent of age and co- characteristics and short-term outcomes of patients with coronavirus
morbidity［J］. J Med Virol，2020，92（10）：2152-2158. disease 2019：a retrospective single-center experience of a
DOI：10.1002/jmv.26003. designated hospital in Poland［J］. Pol Arch Intern Med，2020，
［33］HWANG J M，KIM J H，PARK J S，et al. Neurological diseases 130（5）：407-411. DOI：10.20452/pamw.15361.
as mortality predictive factors for patients with COVID-19：a ［46］OKOH A K，SOSSOU C，DANGAYACH N S，et al. Coronavirus
retrospective cohort study［J］. Neurol Sci，2020，41（9）： disease 19 in minority populations of Newark，New Jersey［J］. Int
2317-2324. DOI：10.1007/s10072-020-04541-z. J Equity Health，2020，19（1）：93. DOI：10.1186/s12939-
［34］LEE J Y，KIM H A，HUH K，et al. Risk factors for mortality and 020-01208-1.
respiratory support in elderly patients hospitalized with COVID-19 ［47］PAN F，YANG L，LI Y C，et al. Factors associated with
in Korea［J］. J Korean Med Sci，2020，35（23）：e223. DOI： death outcome in patients with severe coronavirus disease-19
10.3346/jkms.2020.35.e223. （COVID-19）：a case-control study［J］. Int J Med Sci，
［35］KHALIL K，AGBONTAEN K，MCNALLY D，et al. Clinical 2020，17（9）：1281-1292. DOI：10.7150/ijms.46614.
characteristics and 28-day mortality of medical patients admitted with ［48］PARANJPE I，RUSSAK A J，DE FREITAS J K，et al. Clinical
COVID-19 to a central London teaching hospital［J］. J Infect， characteristics of hospitalized covid-19 patients in New York
2020，81（3）：e85-89. DOI：10.1016/j.jinf.2020.06.027. City［J］. medRxiv，2020：2020.04.19.20062117. DOI：
［36］KLANG E，KASSIM G，SOFFER S，et al. Severe obesity as an 10.1101/2020.04.19.20062117.
independent risk factor for COVID-19 mortality in hospitalized ［49］PARRA-BRACAMONTE G M，LOPEZ-VILLALOBOS N，
patients younger than 50［J］. Obesity （Silver Spring），2020， PARRA-BRACAMONTE F E. Clinical characteristics and risk
28（9）：1595-1599. DOI：10.1002/oby.22913. factors for mortality of patients with COVID-19 in a large data set
［37］KRISHNAN S，PATEL K，DESAI R，et al. Clinical from Mexico［J］. Ann Epidemiol，2020，52：93-98.e2. DOI：
comorbidities，characteristics，and outcomes of mechanically 10.1016/j.annepidem.2020.08.005.
ventilated patients in the State of Michigan with SARS-CoV-2 ［50］RASTAD H，KARIM H，EJTAHED H S，et al. Risk and
pneumonia［J］. J Clin Anesth，2020，67：110005. DOI： predictors of in-hospital mortality from COVID-19 in patients with
10.1016/j.jclinane.2020.110005. diabetes and cardiovascular disease［J］. Diabetol Metab Syndr，
［38］LI Q B，CAO Y L，CHEN L，et al. Hematological features of 2020，12：57. DOI：10.1186/s13098-020-00565-9.
persons with COVID-19［J］. Leukemia，2020，34（8）： ［51］REGALADO-ARTAMENDI I，JIMÉNEZ-UBIETO A，
2163-2172. DOI：10.1038/s41375-020-0910-1. HERNÁNDEZ-RIVAS J Á，et al. Risk factors and mortality
［39］LIEBERMAN-CRIBBIN W，RAPP J，ALPERT N，et al. The of COVID-19 in patients with lymphoma：a multicenter
impact of asthma on mortality in patients with COVID-19［J］. study［J］. Hemasphere，2021，5（3）：e538. DOI：
Chest，2020，158（6）：2290-2291. DOI：10.1016/j. 10.1097/HS9.0000000000000538.
chest.2020.05.575. ［52］RICHARDSON S，HIRSCH J S，NARASIMHAN M，et al.
［40］LIU Q，SONG N C，ZHENG Z K，et al. Laboratory findings and Presenting characteristics，comorbidities，and outcomes among
a combined multifactorial approach to predict death in critically ill 5700 patients hospitalized with COVID-19 in the New York City
patients with COVID-19：a retrospective study［J］. Epidemiol area［J］. JAMA，2020，323（20）：2052-2059. DOI：
Infect，2020，148：e129. DOI：10.1017/S0950268820001442. 10.1001/jama.2020.6775.
［41］LUO M，LIU J，JIANG W L，et al. IL-6 and CD8+ T cell counts ［53］RIVERA-IZQUIERDO M，DEL CARMEN VALERO-UBIERNA
combined are an early predictor of in-hospital mortality of patients M，R-DELAMO J L，et al. Sociodemographic，clinical and
with COVID-19［J］. JCI Insight，2020，5（13）：139024. laboratory factors on admission associated with COVID-19 mortality
DOI：10.1172/jci.insight.139024. in hospitalized patients：a retrospective observational study［J］.
［42］LUO X M，ZHOU W，YAN X J，et al. Prognostic value of C-reactive PLoS One，2020，15（6）：e0235107. DOI：10.1371/journal.
protein in patients with coronavirus 2019［J］. Clin Infect Dis， pone.0235107.
2020，71（16）：2174-2179. DOI：10.1093/cid/ciaa641. ［54］SALACUP G，LO K B，GUL F，et al. Characteristics and clinical
［43］LUO Y，MAO L Y，YUAN X，et al. Prediction model based on outcomes of COVID-19 patients in an underserved-inner city
the combination of cytokines and lymphocyte subsets for prognosis of population：a single tertiary center cohort［J］. J Med Virol，
SARS-CoV-2 infection［J］. J Clin Immunol，2020，40（7）： 2021，93（1）：416-423. DOI：10.1002/jmv.26252.
960-969. DOI：10.1007/s10875-020-00821-7. ［55］SHAH P，OWENS J，FRANKLIN J，et al. Demographics，
［44］MASETTI C，GENERALI E，COLAPIETRO F，et al. comorbidities and outcomes in hospitalized Covid-19 patients in
High mortality in COVID-19 patients with mild respiratory rural southwest Georgia［J］. Ann Med，2020，52（7）：354-
disease［J］. Eur J Clin Invest，2020，50（9）：e13314. DOI： 360. DOI：10.1080/07853890.2020.1791356.
10.1111/eci.13314. ［56］SHAHRIARIRAD R，KHODAMORADI Z，ERFANI A，et al.
［45］NOWAK B，SZYMANSKI P，PANKOWSKI I，et al. Clinical Epidemiological and clinical features of 2019 novel coronavirus